Free Trial

AirSculpt Technologies (AIRS) Competitors

$4.15
-0.16 (-3.71%)
(As of 06/10/2024 ET)

AIRS vs. JYNT, WW, ARA, AUNA, LFMD, SHLT, PTWO, TOI, CANOQ, and CCM

Should you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include Joint (JYNT), WW International (WW), American Renal Associates (ARA), Auna (AUNA), LifeMD (LFMD), SHL Telemedicine (SHLT), Pono Capital Two (PTWO), Oncology Institute (TOI), Cano Health (CANOQ), and Concord Medical Services (CCM).

AirSculpt Technologies vs.

AirSculpt Technologies (NASDAQ:AIRS) and Joint (NASDAQ:JYNT) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, community ranking, earnings, profitability, risk, media sentiment and valuation.

AirSculpt Technologies has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Comparatively, Joint has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500.

AirSculpt Technologies has a net margin of 0.79% compared to Joint's net margin of -9.24%. AirSculpt Technologies' return on equity of 10.13% beat Joint's return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies0.79% 10.13% 4.07%
Joint -9.24%3.94%1.29%

In the previous week, AirSculpt Technologies had 1 more articles in the media than Joint. MarketBeat recorded 1 mentions for AirSculpt Technologies and 0 mentions for Joint. AirSculpt Technologies' average media sentiment score of 0.98 beat Joint's score of 0.00 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company Overall Sentiment
AirSculpt Technologies Positive
Joint Neutral

Joint received 269 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 62.50% of users gave Joint an outperform vote while only 40.74% of users gave AirSculpt Technologies an outperform vote.

CompanyUnderperformOutperform
AirSculpt TechnologiesOutperform Votes
11
40.74%
Underperform Votes
16
59.26%
JointOutperform Votes
280
62.50%
Underperform Votes
168
37.50%

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 76.9% of Joint shares are owned by institutional investors. 78.3% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 30.2% of Joint shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

AirSculpt Technologies currently has a consensus price target of $7.00, indicating a potential upside of 68.67%. Joint has a consensus price target of $22.00, indicating a potential upside of 47.85%. Given AirSculpt Technologies' higher probable upside, equities research analysts plainly believe AirSculpt Technologies is more favorable than Joint.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Joint
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

AirSculpt Technologies has higher revenue and earnings than Joint. Joint is trading at a lower price-to-earnings ratio than AirSculpt Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$195.92M1.22-$4.48M$0.02207.50
Joint$117.70M1.89-$9.75M-$0.75-19.84

Summary

AirSculpt Technologies beats Joint on 12 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIRS vs. The Competition

MetricAirSculpt TechnologiesOffices & clinics of medical doctors IndustryBusiness SectorNASDAQ Exchange
Market Cap$238.92M$862.10M$6.44B$7.52B
Dividend YieldN/AN/A2.92%4.05%
P/E Ratio207.5034.5837.2018.15
Price / Sales1.221.531,268.9493.18
Price / Cash20.3574.5020.2928.09
Price / Book2.849.874.294.31
Net Income-$4.48M-$110.57M$121.99M$215.86M
7 Day Performance-1.19%-5.52%-0.08%-1.33%
1 Month Performance-12.45%0.22%-0.66%0.10%
1 Year Performance-48.19%16.82%3.33%4.32%

AirSculpt Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JYNT
Joint
2.9423 of 5 stars
$15.14
+2.2%
$22.00
+45.3%
+13.3%$226.65M$117.70M-20.19444
WW
WW International
2.9939 of 5 stars
$1.53
-4.4%
$8.09
+428.5%
-76.8%$126.84M$889.55M-0.354,850
ARA
American Renal Associates
0 of 5 stars
$11.52
flat
N/AN/A$397.94M$822.52M-22.154,977
AUNA
Auna
0 of 5 stars
$8.37
-3.5%
$14.15
+69.1%
N/A$618.71MN/A0.0014,958Positive News
LFMD
LifeMD
2.7775 of 5 stars
$7.53
flat
$12.60
+67.3%
+202.8%$318.44M$163.56M-10.18207News Coverage
SHLT
SHL Telemedicine
1.3592 of 5 stars
$5.23
-5.6%
$11.00
+110.3%
-53.9%$81.35M$57.08M0.00583Gap Down
PTWO
Pono Capital Two
0 of 5 stars
$15.08
+8.6%
N/AN/A$72.35MN/A0.00N/ANews Coverage
High Trading Volume
TOI
Oncology Institute
2.067 of 5 stars
$0.45
-2.2%
$2.25
+399.6%
-27.4%$33.53M$324.24M-0.56800Gap Up
CANOQ
Cano Health
0 of 5 stars
$0.27
-12.9%
N/AN/A$1.46M$3.14B0.002,700Gap Down
CCM
Concord Medical Services
0 of 5 stars
$1.94
+145.6%
N/A-50.3%$0.00$75.69M0.00727Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:AIRS) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners